Legacy facilities are getting tough to unload

In contrast to the past, it now takes more than a bargain price to attract a buyer for a redundant pharma manufacturing plant. A strong strategic rationale and revenue stream need to be in the mix for the buyer to achieve viability. Executives are walking away from bargain-basement pricing because of missing long-term economics and strategic rationale. Article


Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.